A Step Ahead Towards
Better Health
  Support
Login
Newsletter
Subscription
F.A.Q. about Angikinase SEDICO (Urokinase 500.000 IU)

How does Angikinase SEDICO is administrated?
Angikinase SEDICO is simply administrated as follow:
The vial is reconstituted in 5 ml saline or sterile water and then diluted in normal saline and given as:
Priming infusion dose 4400 IU / kg at rate of 90 ml / h over 10 minutes
Followed by
Continuous infusion dose 4400 IU/ kg / hour at a rate of 15 ml each hour for 12 - 24 hours

What are the clinical applications of Angikinase SEDICO (Urokinase 500.000 IU)?
Angikinase SEDICO is used clinically as a thrombolytic agent in the treatment of:
Pulmonary embolism
Severe or massive deep venous thrombosis
Recurrent coronary artery thrombosis and Myocardial infarction
Peripheral arterial thrombo-embolism
Some cases of peritonitis
Occluded intravenous or dialysis cannulas

It is also administered intrapleurally to improve the drainage of complicated pleural effusions and empyemas.

Simply, How does Angikinase SEDICO (Urokinase 500.000 IU) work?

Does Angikinase SEDICO effective?
Angikinase SEDICO shows significant reduction of mortality and recurrence of PE:


Konstantinides et Al, 1997

Back

  Home Online Order Useful Links Site Map Privacy Policy  
© 2004 SEDICO Co. All rights reserved
Designed & Developed by EBM Co.